skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Toxicity and repair of DNA adducts produced by the natural product yatakemycin

; ; ORCiD logo
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
OSTI Identifier:
Resource Type:
Journal Article
Resource Relation:
Journal Name: Nature Chemical Biology; Journal Volume: 13; Journal Issue: 9
Country of Publication:
United States

Citation Formats

Mullins, Elwood A., Shi, Rongxin, and Eichman, Brandt F. Toxicity and repair of DNA adducts produced by the natural product yatakemycin. United States: N. p., 2017. Web. doi:10.1038/nchembio.2439.
Mullins, Elwood A., Shi, Rongxin, & Eichman, Brandt F. Toxicity and repair of DNA adducts produced by the natural product yatakemycin. United States. doi:10.1038/nchembio.2439.
Mullins, Elwood A., Shi, Rongxin, and Eichman, Brandt F. 2017. "Toxicity and repair of DNA adducts produced by the natural product yatakemycin". United States. doi:10.1038/nchembio.2439.
title = {Toxicity and repair of DNA adducts produced by the natural product yatakemycin},
author = {Mullins, Elwood A. and Shi, Rongxin and Eichman, Brandt F.},
abstractNote = {},
doi = {10.1038/nchembio.2439},
journal = {Nature Chemical Biology},
number = 9,
volume = 13,
place = {United States},
year = 2017,
month = 7
  • The in vitro anticancer activity and toxicity of phyllostictine A, a novel oxazatricycloalkenone recently isolated from a plant-pathogenic fungus (Phyllosticta cirsii) was characterized in six normal and five cancer cell lines. Phyllostictine A displays in vitro growth-inhibitory activity both in normal and cancer cells without actual bioselectivity, while proliferating cells appear significantly more sensitive to phyllostictine A than non-proliferating ones. The main mechanism of action by which phyllostictine displays cytotoxic effects in cancer cells does not seem to relate to a direct activation of apoptosis. In the same manner, phyllostictine A seems not to bind or bond with DNA asmore » part of its mechanism of action. In contrast, phyllostictine A strongly reacts with GSH, which is a bionucleophile. The experimental data from the present study are in favor of a bonding process between GSH and phyllostictine A to form a complex though Michael attack at C=C bond at the acrylamide-like system. Considering the data obtained, two new hemisynthesized phyllostictine A derivatives together with three other natural phyllostictines (B, C and D) were also tested in vitro in five cancer cell lines. Compared to phyllostictine A, the two derivatives displayed a higher, phyllostictines B and D a lower, and phyllostictine C an almost equal, growth-inhibitory activity, respectively. These results led us to propose preliminary conclusions in terms of the structure-activity relationship (SAR) analyses for the anticancer activity of phyllostictine A and its related compounds, at least in vitro.« less
  • CHO cells of normal or UV-sensitive phenotypes were analyzed for their ability to remove DNA adducts produced by the carcinogen 7-BrMeBA. At a dose of 0.1, which reduced the survival of the normal AA8 cells to approx.90% and the mutant UV5 cells to approx.20%, the frequency of adducts was 5-6 per 10/sup 6/ nucleotides for both cell types, and AA8 cells removed approx.30% of the adducts in 8 h and approx.55% in 24h. In contrast, UV5 and mutants from four other genetic complementation groups had no significant removal. At a dose of mutagen (0.07 resulting in approx.25% survivalmore » of asynchronous UV5, the survival of synchronous cultures rose about threefold from early G/sub 1/ to early S phase and then decreased somewhat in late S/G/sub 2/. At a dose (0.28 producing similar survival of asynchronous cultures, AA8 cells differed qualitatively in that survival decreased progressively by 5- and 10-fold between early G/sub 1/ and the early part of S, and rose steeply through late S/G/sub 2/ to give a 10- to 20-fold increase. The authors conclude that DNA repair is the major determinant of variations in survival through the cycle in normal cells. The patterns observed are consistent with a mechanism of killing in AA8 cells in which adducts disrupt DNA replication, while in UV5 cells transcriptional blocks or other effects may govern lethality. Induced mutations at the aprt and hprt loci showed changes through the cycle in both AA8 and UV5 cells, and patterns were not readily explainable by the action of repair.« less
  • Researchers have examined excision repair of DNA damage in the highly repeated alpha DNA sequence of cultured African green monkey cells. Irradiation of cells with 254 nm ultraviolet light resulted in the same frequency of pyrimidine dimers in alpha DNA and the bulk of the DNA. The rate and extent of pyrimidine dimer removal, as judged by measurement of repair synthesis, was also similar for alpha DNA and bulk DNA. In cells treated with furocoumarins and long-wave-length ultraviolet light, however, repair synthesis in alpha DNA was only 30% of that in bulk DNA, although it followed the same time course.more » Researchers found that this reduced repair was not caused by different initial amounts of furocoumarin damage or by different sizes of repair patches, as researchers found these to be similar in the two DNA species. Direct quantification demonstrated that fewer furocoumarin adducts were removed from alpha DNA than from bulk DNA. In cells treated with another chemical DNA-damaging agent, N-acetoxy-2-acetylaminofluorene, repair synthesis in alpha DNA was 60% of that in bulk DNA. These results show that the repair of different kinds of DNA damage can be affected to different extents by some property of this tandemly repeated heterochromatic DNA. To our knowledge, this is the first demonstration in primate cells of differential repair of cellular DNA sequences.« less
  • The formation and removal of four platinum-DNA adducts were immunochemically quantitated in cultured cells derived from a human bladder carcinoma cell line (RT112) and from two lines derived from germ cell tumors of the testis (833K and SUSA), following exposure in vitro to 16.7 microM (5 micrograms/ml) cisplatin. RT112 cells were least sensitive to the drug and were proficient in the repair of all four adducts, whereas SUSA cells, which were 5-fold more sensitive, were deficient in the repair of DNA-DNA intrastrand cross-links in the sequences pApG and pGpG. Despite expressing a similar sensitivity to SUSA cells, 833K cells weremore » proficient in the repair of all four adducts, although less so than the RT112 bladder tumor cells. In addition, SUSA cells were unable to repair DNA-DNA interstrand cross-links whereas 50-85% of these lesions were removed in RT112 and 833K cells 24 h following drug exposure. It is possible that the inability of SuSa cells to repair platinated DNA may account for their hypersensitivity to cisplatin.« less
  • cis-Platinum compounds, which are used in cancer chemotherapy, are thought to exert their effect by damaging DNA. It is known that this damage is partially repaired in Escherichia coli. Using cis-Pt-treated pBR322 DNA as a probe, the role of nucleotide excision repair in the removal of Pt-DNA adducts was investigated. It was found that the nucleotide excision pathway was the major mechanism for repairing Pt adducts in transforming plasmid DNA but that a recA-dependent pathway also contributed to plasmid survival. When cis-Pt-damaged pBR322 was treated with the purified nucleotide excision enzyme ABC excinuclease in vitro, a fraction of the adductsmore » was removed by the enzyme; this removal resulted in a corresponding increase in transformation efficiency.« less